ASHER DANIEL 4

What Happened
Daniel Asher, a >10% owner of Ekso Bionics (EKSO), reported a purchase of 1,200 shares at $9.60 per share on 2026-02-17, for a total cost of $11,520. The Form 4 (filed 2026-02-19) lists the transaction as code "P" (purchase), which can represent an open-market or private purchase. Purchases are generally considered more informative than routine sales, though this filing does not explain motivation.

Key Details

• Transaction date and price: 2026-02-17 — 1,200 shares @ $9.60 each; total $11,520.
• Filing date: 2026-02-19 (filed within the normal two-business-day window; not reported late).
• Shares owned after transaction: Not specified in the provided filing excerpt.
• Footnotes of note:
  • F1 — Daniel Asher is the beneficial owner of DBA Trading, LLC and controls voting/dispositive power for shares held by that entity.
  • F2 — Daniel Asher is grantor of the Daniel Asher Descendants Trust and controls voting/dispositive power for shares held by the trust.
  • F3 — None.
• Transaction code: P = Purchase (open market or private purchase).

Context
As a 10% owner, Asher is a significant shareholder (not necessarily an executive) and the filing shows control over related entity/trust holdings. The filing does not indicate a 10b5-1 plan, option exercise, gift, or tax-withholding event.